Amarin Corporation plc (AMRN) shares dipped nearly &0% in pre-market trading
after the court ruled against its patent for heart treatment drug Vascepa.
Goldman Sachs lowered the price target for AMRN from $27 to $4. Amarin
shares closed at $13.58 on Monday.
S*********r 发帖数: 2
2
-68%，厉害
trading
【在 b**l 的大作中提到】 : Amarin Corporation plc (AMRN) shares dipped nearly &0% in pre-market trading : after the court ruled against its patent for heart treatment drug Vascepa. : Goldman Sachs lowered the price target for AMRN from $27 to $4. Amarin : shares closed at $13.58 on Monday.
